<SEC-DOCUMENT>0000885725-21-000012.txt : 20210428
<SEC-HEADER>0000885725-21-000012.hdr.sgml : 20210428
<ACCEPTANCE-DATETIME>20210428063438
ACCESSION NUMBER:		0000885725-21-000012
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210428
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210428
DATE AS OF CHANGE:		20210428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		21861246

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bsx-20210428.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:ff73462e-7d80-414d-bf7c-929ea5a58c0a,g:596d1692-079c-4e82-a480-b5ca7247af2b,d:ab724a98e3d640b8b6b3ed37aea06bff--><html xmlns:bsx="http://www.bostonscientific.com/20210428" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bsx-20210428</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl80L2ZyYWc6YjU0NDRmMzI3N2RlNDc2NjkwMDlhMmRiMTQ5M2VmYjcvdGFibGU6NWFhYzA5YzFjOTkxNGI3YWJkNWQ5YjM1MjE3NjI4MzYvdGFibGVyYW5nZTo1YWFjMDljMWM5OTE0YjdhYmQ1ZDliMzUyMTc2MjgzNl8yLTEtMS0xLTA_3d49edb4-5bff-48d2-b99c-08fc2105ab0c">0000885725</ix:nonNumeric><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl80L2ZyYWc6YjU0NDRmMzI3N2RlNDc2NjkwMDlhMmRiMTQ5M2VmYjcvdGFibGU6NWFhYzA5YzFjOTkxNGI3YWJkNWQ5YjM1MjE3NjI4MzYvdGFibGVyYW5nZTo1YWFjMDljMWM5OTE0YjdhYmQ1ZDliMzUyMTc2MjgzNl81LTEtMS0xLTA_4afb7f9c-21e3-487c-8639-f8aa6b08e948">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bsx-20210428.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-28</xbrli:startDate><xbrli:endDate>2021-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i785bcfc838e745908dd8abcc7c606d22_D20210428-20210428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-28</xbrli:startDate><xbrli:endDate>2021-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b50dfb0808e483da456bd627ea01c95_D20210428-20210428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-28</xbrli:startDate><xbrli:endDate>2021-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ce7ace6aade485684be3abae18673d6_D20210428-20210428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-28</xbrli:startDate><xbrli:endDate>2021-04-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iab724a98e3d640b8b6b3ed37aea06bff_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">_____________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU3_6cb931fe-de16-4123-ba72-97daaf551f31">8-K</ix:nonNumeric>  </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">_____________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8zNjc_c3a7fb33-7ced-4549-a556-eb8d8d696002">April 28, 2021</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU4_9b4f7dd6-f5bd-4909-af07-1d16db58b82a">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MjAwNzIyYjI4YTZmNGVkOTg1NzM3YTI1NWU4Yjk4YzEvdGFibGVyYW5nZToyMDA3MjJiMjhhNmY0ZWQ5ODU3MzdhMjU1ZThiOThjMV8wLTAtMS0xLTA_90a42787-93f4-4fdf-bdc7-1e7517fe6891">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MjAwNzIyYjI4YTZmNGVkOTg1NzM3YTI1NWU4Yjk4YzEvdGFibGVyYW5nZToyMDA3MjJiMjhhNmY0ZWQ5ODU3MzdhMjU1ZThiOThjMV8wLTItMS0xLTA_2bc4e865-44ce-42c0-bd6a-ba9acbbbf1ba">1-11083</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MjAwNzIyYjI4YTZmNGVkOTg1NzM3YTI1NWU4Yjk4YzEvdGFibGVyYW5nZToyMDA3MjJiMjhhNmY0ZWQ5ODU3MzdhMjU1ZThiOThjMV8wLTQtMS0xLTA_7be986cc-f0e6-4d2d-9dbd-b9ac9b9cf8c6">04-2695240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU5_48d7dc24-e065-4336-b36a-f3a479daf2fe">300 Boston Scientific Way</ix:nonNumeric>, <ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDYw_ebb639a6-c4a2-4cf7-b25b-514747404e9f">Marlborough</ix:nonNumeric>, <ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU0_1f28900e-7fec-4e0f-b374-8562cbbfb59f">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU1_e2d64ccc-2cef-48b6-8f0c-4a083cbb2ee8">01752-1234</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;             &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDUy_450c1b2f-8d03-46b5-839e-258e51c883fc">508</ix:nonNumeric> <ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU2_c5dc1ece-dc20-4a1f-9a5f-ef9b5e739249">683-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6YzcxMzU0ZWE4ZTYxNDgxOWFmOWU5YTRiMDQ2ZjE4MDkvdGFibGVyYW5nZTpjNzEzNTRlYThlNjE0ODE5YWY5ZTlhNGIwNDZmMTgwOV8wLTAtMS0xLTA_061cde8b-cc4f-4c7d-9d3a-05de31399e56">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6YzcxMzU0ZWE4ZTYxNDgxOWFmOWU5YTRiMDQ2ZjE4MDkvdGFibGVyYW5nZTpjNzEzNTRlYThlNjE0ODE5YWY5ZTlhNGIwNDZmMTgwOV8yLTAtMS0xLTA_5a1380bd-fd4a-49a0-a0da-3d9b837c2e2c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6YzcxMzU0ZWE4ZTYxNDgxOWFmOWU5YTRiMDQ2ZjE4MDkvdGFibGVyYW5nZTpjNzEzNTRlYThlNjE0ODE5YWY5ZTlhNGIwNDZmMTgwOV80LTAtMS0xLTA_a30c481f-691a-4f1e-aaee-ea0a0162e613">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6YzcxMzU0ZWE4ZTYxNDgxOWFmOWU5YTRiMDQ2ZjE4MDkvdGFibGVyYW5nZTpjNzEzNTRlYThlNjE0ODE5YWY5ZTlhNGIwNDZmMTgwOV82LTAtMS0xLTA_f65316ce-6e3e-4338-a8a7-7f9760f3adb5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.414%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i785bcfc838e745908dd8abcc7c606d22_D20210428-20210428" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18xLTAtMS0xLTA_b1869a2a-60c9-4ed0-b6eb-89f20254d842">Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i785bcfc838e745908dd8abcc7c606d22_D20210428-20210428" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18xLTItMS0xLTA_551530b6-7b9b-42cf-b1de-f963cf64262a">BSX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i785bcfc838e745908dd8abcc7c606d22_D20210428-20210428" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18xLTQtMS0xLTA_5c6fa9c7-b6a1-4204-9ce1-8d553288eebe">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b50dfb0808e483da456bd627ea01c95_D20210428-20210428" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18yLTAtMS0xLTA_4ac06afb-0edb-483e-9430-cf5c60c2dd29">0.625% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b50dfb0808e483da456bd627ea01c95_D20210428-20210428" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18yLTItMS0xLTA_e2e86a5c-e9d8-4220-9b35-5ccc583f45a0">BSX27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b50dfb0808e483da456bd627ea01c95_D20210428-20210428" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18yLTQtMS0xLTA_4f864e70-a1d2-4b60-bd3a-0e44ec328bdb">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ce7ace6aade485684be3abae18673d6_D20210428-20210428" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18zLTAtMS0xLTA_fa2e29cc-5734-4b66-a1c0-87aefee44efb">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ce7ace6aade485684be3abae18673d6_D20210428-20210428" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18zLTItMS0xLTA_74cdb4d6-5402-41e1-9b93-6c774fe06b7f">BSX PR A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ce7ace6aade485684be3abae18673d6_D20210428-20210428" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18zLTQtMS0xLTA_f3f80083-ecfc-4e08-acba-dfb5a2ad91ce">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-top:6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDUz_4a28c295-c510-4609-8bce-992975f8314d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="iab724a98e3d640b8b6b3ed37aea06bff_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.02.&#160;&#160;&#160;&#160;RESULTS OF OPERATIONS AND FINANCIAL CONDITION.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;28, 2021, Boston Scientific Corporation issued a press release announcing financial results for the first quarter ended March&#160;31, 2021.  A copy of the release is furnished with this report as Exhibit 99.1. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.01. &#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND EXHIBITS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;Exhibits</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit No.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Description</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="q12021earningsrelease.htm">Press Release issued by Boston Scientific Corporation dated April 28, 2021</a></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;document</span></div><div><span><br/></span></div><div id="iab724a98e3d640b8b6b3ed37aea06bff_10"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.341%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BOSTON SCIENTIFIC CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Vance R. Brown</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vance R. Brown</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and Chief Corporate Counsel</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>q12021earningsrelease.htm
<DESCRIPTION>EX-99.1 Q1 2021 EARNINGS RELEASE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i175e91026af44876af4813e97fae6b6c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><img alt="letterheadlogoa521.jpg" src="letterheadlogoa521.jpg" style="height:107px;margin-bottom:5pt;vertical-align:text-bottom;width:682px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FOR IMMEDIATE RELEASE</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2021</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Marlborough, Mass. (April&#160;28, 2021) -- Boston Scientific Corporation (NYSE&#58; BSX) generated net sales of $2.752 billion during the first quarter of 2021. This represents growth of 8.2 percent on a reported basis, 5.6 percent on an operational</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> basis and 5.9 percent on an organic</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> basis, all compared to the prior year period. The company reported GAAP net income available to common stockholders of $327 million or $0.23 per share (EPS), compared to GAAP net income of $11 million or $0.01 per share a year ago, and achieved adjusted EPS of $0.37 for the period, compared to $0.28 a year ago.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;We are pleased by the trajectory of our recovery,&#8221; said Mike Mahoney, chairman and chief executive officer, Boston Scientific. &#8220;Our global team remains committed to helping patients and our customers by delivering a robust portfolio of innovative solutions, and that commitment will continue to fuel our future growth.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">First quarter financial results and recent developments&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Reported net sales of $2.752 billion, representing an increase of 8.2 percent on a reported basis, compared to the company's guidance range of  0 to 6 percent&#59; 5.6 percent on an operational basis&#59; and 5.9 percent on an organic basis, compared to the company's guidance range of  (3) to 3 percent, all compared to the prior year period.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Reported GAAP net income available to common stockholders of $0.23 per share compared to the company's guidance range of $0.05 to $0.11 per share. Achieved adjusted EPS of $0.37 compared to the guidance range of $0.28 to $0.34 per share.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Achieved net sales growth in each reportable segment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, compared to the prior year period&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">MedSurg&#58; 11.1 percent reported, 8.6 percent operational and 9.5 percent organic </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Rhythm and Neuro&#58; 6.8 percent reported, 4.0 percent operational and 1.6 percent organic</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Cardiovascular&#58; 10.0 percent reported, 7.4 percent operational and organic</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Achieved the following regional</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> net sales growth, compared to the prior year period&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">U.S.&#58; 8.6 percent reported and operational</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">EMEA (Europe, Middle East and Africa)&#58; 9.4 percent reported and 1.9 percent operational</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">APAC (Asia-Pacific)&#58; 15.6 percent reported and 9.1 percent operational</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Emerging Markets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; 16.0 percent reported and 13.2 percent operational</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Received U.S. Food and Drug Administration (FDA) approval for the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">TheraSphere&#8482; Y-90 Glass Microspheres</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> for the treatment of patients with hepatocellular carcinoma, the most common type of primary liver cancer, and secured FDA Breakthrough Device designation for TheraSphere treatment for patients with glioblastoma, a type of brain cancer.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Received approval for the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Ranger&#8482; Drug-Coated Balloon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> from Japan's Ministry of Health, Labor and Welfare (MHLW) and initiated a full launch in the region.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Launched </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Vercise Genus&#8482; Deep Brain Stimulation (DBS) System </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">in the U.S. Additionally, the system is being used with the world&#8217;s first 16-channel directional leads&#8212;Cartesia&#8482; X and HX leads&#8212;in the eXTend 3D Study in Europe.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Commenced U.S. launch of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">WaveWriter Alpha&#8482;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> portfolio of spinal cord stimulator (SCS) systems, consisting of four full-body MR conditional, Bluetooth-enabled devices, new </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">FAST</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> paresthesia-free therapy and all supported by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Cognita&#8482; Solutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8212;a suite of digital tools that helps physicians and patients navigate the pain management journey.   </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Surpassed 50,000 patients worldwide treated with the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">SENTINEL&#8482; Cerebral Protection System</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, the first and only FDA-cleared device to protect patients from stroke risk during transcatheter aortic valve replacement (TAVR) procedures.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Published positive 12-month results from the PINNACLE FLX clinical trial in Circulation, demonstrating the next-generation </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Device</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> is a safe and effective alternative to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation and increased risk of bleeding. The trial met its primary safety endpoint with a low adverse event rate of 0.5%, as well as its primary effectiveness endpoint with a 100% rate of LAA closure at 12 months.  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Presented five-year outcomes from the EFFORTLESS study, the largest post-market registry of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Subcutaneous Implantable Defibrillator (S-ICD) System</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, further validating the long-term efficacy of the device. Results demonstrated 98% overall efficacy over five years, consistent with results of previous S-ICD studies and comparable to or higher than many large transvenous ICD studies. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Received FDA approval to modify the design of the ACURATE IDE trial&#8212;evaluating the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">ACURATE neo2&#8482; Aortic Valve System</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8212;to an &#34;all-risk&#34; protocol to study patients with severe, symptomatic aortic stenosis who are at low risk of open-heart surgery, in addition to those at intermediate, high and extreme risk.  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Initiated the NEwTON AF IDE clinical trial to evaluate the safety and effectiveness of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">INTELLANAV STABLEPOINT&#8482; Ablation Catheter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> enabled with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">DIRECTSENSE&#8482; Technology</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> in patients with paroxysmal atrial fibrillation. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Named eighth on the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Forbes </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">list of America&#8217;s Best Employers for Diversity 2021, based on a survey of 50,000 Americans working for businesses with at least 1,000 employees. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Completed the acquisition of Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, for an upfront cash payment of &#126;$720 million, with up to an additional &#126;$230 million in a potential commercial milestone payment, given a preexisting 22 percent equity stake.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Completed the sale of the BTG Specialty Pharmaceuticals business to Stark International Lux S.A.R.L. and SERB SAS, affiliates of SERB, for &#126;$800 million in cash. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Announced a definitive agreement with an affiliate of Baring Private Equity Asia to acquire the global surgical business of Lumenis LTD., a privately-held company that develops and </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">commercializes energy-based medical solutions, for an upfront cash payment of &#126;$1.07 billion, subject to customary closing conditions and adjustments.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Announced plans to host a virtual Investor Day business review meeting for the investment community on Wednesday, September 22, 2021.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:105%">1. Operational net sales growth excludes the impact of foreign currency fluctuations.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">2. Organic net sales growth excludes the impact of foreign currency fluctuations and net sales from the recent acquisition of Preventice Solutions, Inc. (Preventice). Organic net sales growth rates also exclude the intrauterine health franchise, which we divested in Q2 2020 and the Specialty Pharmaceuticals business, which we divested in Q1 2021.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">3 We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries&#58; Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior year amounts to conform to the current year's presentation. The revision had an immaterial impact on previously reported Emerging Markets net sales.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">4. We have three historical reportable segments comprised of Medical Surgical (MedSurg), Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices (Medical Devices). </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">5. On March 1, 2021, we completed the sale of the Specialty Pharmaceuticals business. Our consolidated net sales include Specialty Pharmaceuticals up to the date of the closing of the transaction. Specialty Pharmaceuticals net sales were substantially U.S. based and presented as a stand-alone operating segment alongside our Medical Device Reportable segments.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">6. Consistent with Section 515B of the FD&#38;C Act, devices designated as Breakthrough Devices will receive prioritized review (Section II.F).</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Net sales for the first quarter by business and region&#58;</font></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change</font></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Three Months Ended<br>March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reported Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Less&#58; Impact of Foreign Currency Fluctuations</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operational<br>&#160;Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Less&#58; <br>Impact of Recent Acquisitions &#47; Divestitures</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Organic Basis</font></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Endoscopy</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">499&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">442&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Urology and Pelvic Health</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">361&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">332&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">MedSurg</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">860</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">774</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(0.9)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">9.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cardiac Rhythm Management</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">469&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">437&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Electrophysiology</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">74&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Neuromodulation</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">191&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Rhythm and Neuro</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">750</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">703</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">4.0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interventional Cardiology</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">696&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">633&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Peripheral Interventions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">433&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">392&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cardiovascular</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1,129</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1,026</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">10.0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Medical Devices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2,739</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2,502</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">5</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">41</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(67.5)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(68.0)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(23.6)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(44.4)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net Sales</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2,752</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2,543</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(0.3)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">5.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</font></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less&#58; Impact of Foreign Currency Fluctuations</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operational<br>&#160;Basis</font></td></tr><tr style="height:17pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,577&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,452&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EMEA</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">604&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">552&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">APAC</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">473&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">409&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Latin America and Canada</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Medical Devices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2,739</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2,502</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">9.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">5</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">41</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(67.5)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(68.0)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net Sales</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2,752</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2,543</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Emerging Markets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">3</font></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">317</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">273</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">16.0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">13.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Amounts may not add due to rounding. Growth rates are based on actual, non-rounded amounts and may not recalculate precisely.</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Growth rates that exclude the impact of foreign currency fluctuations and&#47;or the impact of recent aforementioned acquisitions &#47; divestitures are not prepared in accordance with U.S. GAAP.</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Guidance for Full Year and Second Quarter 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The company now estimates net sales growth for the full year 2021, versus the prior year period, to be in a range of approximately 16 to 19 percent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">on a reported basis, and approximately 15 to 18 percent on an organic basis. Full year organic net sales guidance excludes the impact of foreign currency fluctuations and the acquisition of Preventice Solutions, Inc., with no prior period related net sales, as well as the intrauterine health franchise, which we divested in Q2 2020 and the Specialty Pharmaceuticals business, which we divested in Q1 2021. The company now estimates earnings on a GAAP basis in a range of $0.81 to $0.88 per share and estimates adjusted earnings, excluding certain charges (credits), of $1.53 to $1.60 per share.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The company estimates net sales growth for the second quarter of 2021, versus the prior year period, to be in a range of approximately 46 to 50 percent on a reported basis and approximately 44 to 48 percent on an organic basis. Second quarter organic net sales guidance excludes the impact of foreign currency fluctuations and the acquisition of Preventice, with no prior period related net sales, as well as the intrauterine health franchise, which we divested in Q2 2020 and the Specialty Pharmaceuticals business, which we divested in Q1 2021. The company estimates earnings on a GAAP basis in a range of $0.16 to $0.18 per share and adjusted earnings, excluding certain charges (credits), of $0.36 to $0.38 per share.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Conference Call Information</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Boston Scientific management will be discussing these results with analysts on a conference call today at 8&#58;00 a.m. ET. The company will webcast the call to interested parties through its website&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.bostonscientific.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Please see the website for details on how to access the webcast. The webcast will be available for approximately one year on the Boston Scientific website.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Boston Scientific</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.&#160; As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.bostonscientific.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and connect on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Twitter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Facebook</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Statements </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.&#160;Forward-looking statements may be identified by words like &#34;anticipate,&#34; &#34;expect,&#34; &#34;project,&#34; &#34;believe,&#34; &#34;plan,&#34; &#34;estimate,&#34; &#34;intend&#34; and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.&#160;These forward-looking statements include, among other things, statements regarding our expected net sales&#59; GAAP, operational and organic revenue growth rates&#59; GAAP earnings and adjusted earnings for the second quarter and full year 2021&#59; our financial performance&#59; our business plans and product performance&#59; and the impact of the COVID-19 pandemic on the company's results of operations.&#160;If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.&#160;These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">release.&#160;As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Factors that may cause such differences include, among other things&#58; future economic, political, competitive, reimbursement and regulatory conditions&#59; new product introductions&#59; demographic trends&#59; intellectual property&#59; litigation&#59; financial market conditions&#59; and future business decisions made by us and our competitors.&#160;All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.&#160;For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A -&#160;Risk Factors&#160;in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A -&#160;Risk Factors&#160;in Quarterly Reports on Form 10-Q we have filed or will file hereafter.&#160;We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.&#160;This cautionary statement is applicable to all forward-looking statements contained in this press release.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; Amounts reported in millions within this press release are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Use of Non-GAAP Financial Information</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A reconciliation of the company's non-GAAP financial measures to the corresponding GAAP measures, and an explanation of the company's use of these non-GAAP financial measures,&#160;is included in the exhibits attached to this press release.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CONTACT&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Media&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kate Haranis</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Investors&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Susie Lisa, CFA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">508-683-6585 (office)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">508-683-5565 (office)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Media Relations</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Investor Relations</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Boston Scientific Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Boston Scientific Corporation</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">kate.haranis&#64;bsci.com</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">BSXInvestorRelations&#64;bsci.com</font></div></td></tr></table></div><div id="i175e91026af44876af4813e97fae6b6c_7"></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.690%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions, except per share data</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of business</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss)&#160;before income taxes</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) available to common stockholders</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">327</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share - basic</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share - assuming dilution</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Weighted-average shares outstanding</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assuming dilution</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">NON-GAAP NET INCOME AND NET INCOME PER SHARE RECONCILIATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Expenses</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Preferred Stock Dividends</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss) Available to Common Stockholders</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact per Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,858</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,488</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">370</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(45)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">325</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">341</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">327</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Non-GAAP adjustments&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(185)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">185&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">185&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">167&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">167&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition &#47; divestitures-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(37)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(198)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(148)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.11)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EU MDR implementation costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discrete tax items</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.00)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,897</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,228</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">669</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(97)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">572</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">538</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">524</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.37</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">(1) For the three months ended March 31, 2021, the effect of assuming the conversion of Mandatory Convertible Preferred Stock (MCPS) into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP net income and adjusted net income were reduced by cumulative Preferred stock dividends, as presented in our unaudited consolidated statements of operations, for purposes of calculating net income available to common stockholders.</font></div></td></tr><tr style="height:12pt"><td colspan="30" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Expenses</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Preferred Stock Dividends</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss) Available to Common Stockholders</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact per Share</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,737</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,591</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">146</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(124)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Non-GAAP adjustments&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(201)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible asset impairment charges </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(198)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">168&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition &#47; divestitures-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EU MDR implementation costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discrete tax items</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,794</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,245</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">549</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(115)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">434</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">391</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">391</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">An explanation of the company's use of these non-GAAP financial measures is provided at the end of this document.</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 and FY 2021 GUIDANCE RECONCILIATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">   </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Net Sales</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2021 Estimate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Full Year 2021 Estimate</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated GAAP sales growth</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less&#58; Estimated impact of foreign currency fluctuations</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated sales growth, operational</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less&#58; Estimated impact of recent acquisitions &#47; divestitures</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated sales growth, organic</font></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Earnings per Share</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2021 Estimate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Full Year 2021 Estimate</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP results</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.81</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.88</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.45&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.45&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated acquisition &#47; divestitures-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.04)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.04)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated restructuring and restructuring-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated other adjustments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.19&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.19&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted results</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.36</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.38</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.53</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i175e91026af44876af4813e97fae6b6c_13"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share (EPS) that exclude certain amounts, operational net sales, which exclude the impact of foreign currency fluctuations and organic net sales, which exclude the impact of foreign currency fluctuations and the impact of recent aforementioned acquisitions and divestitures. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes. </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To calculate adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share we exclude certain charges (credits) from GAAP net income and GAAP net income available to common stockholders. Amounts are presented after-tax at the company's effective tax rate, unless the amount is a significant unusual or infrequently occurring item in accordance with FASB Accounting Standards Codification section 740-270-30, &#34;General Methodology and Use of Estimated Annual Effective Tax Rate.&#34; Please refer to Part II, Item 7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in our most recent Annual Report filed on Form 10-K filed with the Securities and Exchange Commission or any Quarterly Report on Form 10-Q that we file thereafter for an explanation of each of these adjustments and the reasons for excluding each item. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The GAAP financial measures most directly comparable to adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share are GAAP net income (loss), GAAP net income (loss) available to common stockholders and GAAP net income (loss) per common share - assuming dilution, respectively. </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To calculate operational net sales growth rates, which exclude the impact of foreign currency fluctuations, we convert actual net sales from local currency to U.S. dollars using constant foreign currency exchange rates in the current and prior periods. To calculate organic net sales growth rates, we also remove the impact of recent aforementioned acquisitions and divestitures with less than a full period of comparable net sales. The GAAP financial measure most directly comparable to operational net sales and organic net sales is net sales on a GAAP basis. </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Reconciliations of each of these non-GAAP financial measures to the corresponding GAAP financial measure are included in the accompanying schedules.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Management uses these supplemental non-GAAP financial measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors and to establish operational goals and forecasts that are used in allocating resources. In addition, management uses these non-GAAP financial measures to further its understanding of the performance of our operating segments. The adjustments excluded from our non-GAAP financial measures are consistent with those excluded from our operating segments&#8217; measures of net sales and profit or loss. These adjustments are excluded from the segment measures reported to our chief operating decision maker that are used to make operating decisions and assess performance. </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We believe that presenting adjusted net income (loss), adjusted net income (loss) available to common stockholders, adjusted net income (loss) per share, operational net sales and organic net sales, in addition to the corresponding GAAP financial measures, provides investors greater transparency to the information used by management for its operational decision-making and allows investors to see our results &#8220;through the eyes&#8221; of management. We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bsx-20210428.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ff73462e-7d80-414d-bf7c-929ea5a58c0a,g:596d1692-079c-4e82-a480-b5ca7247af2b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bsx="http://www.bostonscientific.com/20210428" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bostonscientific.com/20210428">
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210428_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210428_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210428_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210428_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverDocument" roleURI="http://www.bostonscientific.com/role/CoverDocument">
        <link:definition>0001001 - Document - Cover Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bsx_SeniorNotedue2027Member" abstract="true" name="SeniorNotedue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_A550MCPSSeriesAMember" abstract="true" name="A550MCPSSeriesAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>bsx-20210428_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ff73462e-7d80-414d-bf7c-929ea5a58c0a,g:596d1692-079c-4e82-a480-b5ca7247af2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20210428.xsd#CoverDocument"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>bsx-20210428_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ff73462e-7d80-414d-bf7c-929ea5a58c0a,g:596d1692-079c-4e82-a480-b5ca7247af2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20210428.xsd#CoverDocument"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended" id="i514e6c85f9ee4b4d80a9878e47dec86a_CoverDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4abfd7b3-18da-4e6d-9a05-f4f19bfd2534" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_DocumentType_4abfd7b3-18da-4e6d-9a05-f4f19bfd2534" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7f052de9-9c73-4a87-b5e8-247486c1aa07" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_DocumentPeriodEndDate_7f052de9-9c73-4a87-b5e8-247486c1aa07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d1d493ff-ace0-44b8-8cec-189c8f4ed2c0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityRegistrantName_d1d493ff-ace0-44b8-8cec-189c8f4ed2c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d12596f4-86f8-4a84-9aa4-f17aca9c887b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_AmendmentFlag_d12596f4-86f8-4a84-9aa4-f17aca9c887b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_71845dc1-709a-4acd-a04c-58853aaf50ba" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityIncorporationStateCountryCode_71845dc1-709a-4acd-a04c-58853aaf50ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_be7bcc7f-9dad-4ba7-9a3b-5da3f47bc91e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityFileNumber_be7bcc7f-9dad-4ba7-9a3b-5da3f47bc91e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e7f24143-28ea-4cdd-9fe0-b4f5f24e419b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityTaxIdentificationNumber_e7f24143-28ea-4cdd-9fe0-b4f5f24e419b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_083515dc-191d-46bd-99fc-84a63197bf49" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityAddressAddressLine1_083515dc-191d-46bd-99fc-84a63197bf49" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9aa858ef-85fd-4d0b-841f-500eaf5400aa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityAddressCityOrTown_9aa858ef-85fd-4d0b-841f-500eaf5400aa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_62105041-cb83-4242-9ab0-1f98caec524f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityAddressStateOrProvince_62105041-cb83-4242-9ab0-1f98caec524f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_922d84a6-33f9-4190-9122-f590baaabde2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityAddressPostalZipCode_922d84a6-33f9-4190-9122-f590baaabde2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_1cb945d9-1cc4-4d36-90b5-bf1baddb26ca" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_CityAreaCode_1cb945d9-1cc4-4d36-90b5-bf1baddb26ca" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ac4d2e26-3843-4542-ac2c-210f7656c684" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_LocalPhoneNumber_ac4d2e26-3843-4542-ac2c-210f7656c684" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_c1fe44f0-c391-475d-9f40-8100e4f0889c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_WrittenCommunications_c1fe44f0-c391-475d-9f40-8100e4f0889c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_150b047c-2951-4d1e-8f72-aa770559003c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_SolicitingMaterial_150b047c-2951-4d1e-8f72-aa770559003c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_04c0fa07-0500-43bd-9d12-f05946c78dc1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_PreCommencementTenderOffer_04c0fa07-0500-43bd-9d12-f05946c78dc1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_197501e0-d138-434e-b315-cc32047a2de6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_197501e0-d138-434e-b315-cc32047a2de6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_21f91b75-cb04-45bc-920c-33da5053db64" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_Security12bTitle_21f91b75-cb04-45bc-920c-33da5053db64" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_e2639c12-d795-4062-9f56-dd42dec4b4ce" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_TradingSymbol_e2639c12-d795-4062-9f56-dd42dec4b4ce" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f1172c11-cca9-4ff4-98c6-690ddea57413" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_SecurityExchangeName_f1172c11-cca9-4ff4-98c6-690ddea57413" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_efc71e43-f129-4a44-9502-644d954cf0fc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityEmergingGrowthCompany_efc71e43-f129-4a44-9502-644d954cf0fc" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_20f1c46e-6bce-47ac-b1e0-aa686ef84d9f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityCentralIndexKey_20f1c46e-6bce-47ac-b1e0-aa686ef84d9f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_cd3bc8ea-59c2-4ad0-b1d9-8bca88117b25" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntitiesTable_cd3bc8ea-59c2-4ad0-b1d9-8bca88117b25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_775049cb-e6ee-4e51-9719-4d8e69db30e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_cd3bc8ea-59c2-4ad0-b1d9-8bca88117b25" xlink:to="loc_us-gaap_StatementClassOfStockAxis_775049cb-e6ee-4e51-9719-4d8e69db30e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_775049cb-e6ee-4e51-9719-4d8e69db30e8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_775049cb-e6ee-4e51-9719-4d8e69db30e8" xlink:to="loc_us-gaap_ClassOfStockDomain_775049cb-e6ee-4e51-9719-4d8e69db30e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_37a765df-d050-4a74-98c0-96ad87ac27e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_775049cb-e6ee-4e51-9719-4d8e69db30e8" xlink:to="loc_us-gaap_ClassOfStockDomain_37a765df-d050-4a74-98c0-96ad87ac27e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ad776f5b-d9ad-4415-8411-9cc3442fcdcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_37a765df-d050-4a74-98c0-96ad87ac27e9" xlink:to="loc_us-gaap_CommonStockMember_ad776f5b-d9ad-4415-8411-9cc3442fcdcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_cc61e420-6d0b-4509-b3a8-1a1a6b50c2ef" xlink:href="bsx-20210428.xsd#bsx_SeniorNotedue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_37a765df-d050-4a74-98c0-96ad87ac27e9" xlink:to="loc_bsx_SeniorNotedue2027Member_cc61e420-6d0b-4509-b3a8-1a1a6b50c2ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_e9f7765a-d4fe-4bff-b025-16626eb19ad5" xlink:href="bsx-20210428.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_37a765df-d050-4a74-98c0-96ad87ac27e9" xlink:to="loc_bsx_A550MCPSSeriesAMember_e9f7765a-d4fe-4bff-b025-16626eb19ad5" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bsx-20210428_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ff73462e-7d80-414d-bf7c-929ea5a58c0a,g:596d1692-079c-4e82-a480-b5ca7247af2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_bsx_A550MCPSSeriesAMember_185014f8-7491-4dc2-928c-c4f33076353c_terseLabel_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_label_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_documentation_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember" xlink:href="bsx-20210428.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A550MCPSSeriesAMember" xlink:to="lab_bsx_A550MCPSSeriesAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b5788475-166c-43fc-a87b-d710281dff94_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3f0064a3-247d-4db3-a9cd-501d93e3fffe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_f7be0a1d-c56a-4fac-bc31-c0f0090d6737_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ac16426b-a238-4db1-89d3-3733a706470e_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b5f134c2-e5a4-4366-a6da-7ec7bac2e5c7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f52293b2-2512-465a-9e14-ab4398203ae0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d93dabe6-938e-424a-8e21-2cb78c237fcf_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_4c9d018b-cbb8-48d7-8848-db58dfa69a40_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_cd5f52b6-ba27-4639-a2f0-8644d0382752_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_873ba7ed-b7cb-4355-a533-47fc2854d738_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c921f0e8-1761-4ee1-802b-4e557ac5d244_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ad743027-fe37-40ed-a536-9a1403921f75_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_acee6d9d-5193-4412-bb2d-9c5ff2d0ec6b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_78012930-6272-44f9-8476-b4d3b1f37bfe_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c8fc0431-290d-4617-834c-3ca6592bd341_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c6a48ce4-2866-4b0c-b00f-651c34fdc720_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_da176049-0d6e-4de4-874f-f3db82dd18f9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_ecedd10a-ec86-4e63-94c6-0888900335f7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6f91a73a-89db-4314-adc4-9fe83ad5320c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SeniorNotedue2027Member_8af42ced-a292-4d28-8b1c-4aea8e252156_terseLabel_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_label_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_documentation_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member" xlink:href="bsx-20210428.xsd#bsx_SeniorNotedue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SeniorNotedue2027Member" xlink:to="lab_bsx_SeniorNotedue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_1a5a9966-752e-41f5-9f17-e163207663cd_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_ca568d0f-0893-479a-8764-30b6ed78e11d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_0d64b6a1-19e5-4149-bdc9-f585aaa88ecb_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bd95e8da-bf9a-42c6-b1a4-9d42771a6fb2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_dfb8a2f4-a89c-46cb-b3ce-c4e5113bc019_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_9bc1f3ae-56a9-4e4a-be23-a125afb2b324_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_cd65d4d2-e006-40a2-8a8a-39edf762f5a5_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6e3ea0c1-6e1e-4aa0-b33d-7cea8c8d6377_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_ff81aa90-db2f-4ea2-a2af-88054b98935b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bsx-20210428_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ff73462e-7d80-414d-bf7c-929ea5a58c0a,g:596d1692-079c-4e82-a480-b5ca7247af2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20210428.xsd#CoverDocument"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d1ee5f02-5b05-411d-a298-7a9a9e96d84c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_cd3bc8ea-59c2-4ad0-b1d9-8bca88117b25" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1ee5f02-5b05-411d-a298-7a9a9e96d84c" xlink:to="loc_dei_EntitiesTable_cd3bc8ea-59c2-4ad0-b1d9-8bca88117b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_775049cb-e6ee-4e51-9719-4d8e69db30e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_cd3bc8ea-59c2-4ad0-b1d9-8bca88117b25" xlink:to="loc_us-gaap_StatementClassOfStockAxis_775049cb-e6ee-4e51-9719-4d8e69db30e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_37a765df-d050-4a74-98c0-96ad87ac27e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_775049cb-e6ee-4e51-9719-4d8e69db30e8" xlink:to="loc_us-gaap_ClassOfStockDomain_37a765df-d050-4a74-98c0-96ad87ac27e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ad776f5b-d9ad-4415-8411-9cc3442fcdcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_37a765df-d050-4a74-98c0-96ad87ac27e9" xlink:to="loc_us-gaap_CommonStockMember_ad776f5b-d9ad-4415-8411-9cc3442fcdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_cc61e420-6d0b-4509-b3a8-1a1a6b50c2ef" xlink:href="bsx-20210428.xsd#bsx_SeniorNotedue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_37a765df-d050-4a74-98c0-96ad87ac27e9" xlink:to="loc_bsx_SeniorNotedue2027Member_cc61e420-6d0b-4509-b3a8-1a1a6b50c2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_e9f7765a-d4fe-4bff-b025-16626eb19ad5" xlink:href="bsx-20210428.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_37a765df-d050-4a74-98c0-96ad87ac27e9" xlink:to="loc_bsx_A550MCPSSeriesAMember_e9f7765a-d4fe-4bff-b025-16626eb19ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_cd3bc8ea-59c2-4ad0-b1d9-8bca88117b25" xlink:to="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4abfd7b3-18da-4e6d-9a05-f4f19bfd2534" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_DocumentType_4abfd7b3-18da-4e6d-9a05-f4f19bfd2534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7f052de9-9c73-4a87-b5e8-247486c1aa07" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_DocumentPeriodEndDate_7f052de9-9c73-4a87-b5e8-247486c1aa07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d1d493ff-ace0-44b8-8cec-189c8f4ed2c0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityRegistrantName_d1d493ff-ace0-44b8-8cec-189c8f4ed2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d12596f4-86f8-4a84-9aa4-f17aca9c887b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_AmendmentFlag_d12596f4-86f8-4a84-9aa4-f17aca9c887b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_71845dc1-709a-4acd-a04c-58853aaf50ba" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityIncorporationStateCountryCode_71845dc1-709a-4acd-a04c-58853aaf50ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_be7bcc7f-9dad-4ba7-9a3b-5da3f47bc91e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityFileNumber_be7bcc7f-9dad-4ba7-9a3b-5da3f47bc91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e7f24143-28ea-4cdd-9fe0-b4f5f24e419b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityTaxIdentificationNumber_e7f24143-28ea-4cdd-9fe0-b4f5f24e419b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_083515dc-191d-46bd-99fc-84a63197bf49" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityAddressAddressLine1_083515dc-191d-46bd-99fc-84a63197bf49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9aa858ef-85fd-4d0b-841f-500eaf5400aa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityAddressCityOrTown_9aa858ef-85fd-4d0b-841f-500eaf5400aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_62105041-cb83-4242-9ab0-1f98caec524f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityAddressStateOrProvince_62105041-cb83-4242-9ab0-1f98caec524f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_922d84a6-33f9-4190-9122-f590baaabde2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityAddressPostalZipCode_922d84a6-33f9-4190-9122-f590baaabde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_1cb945d9-1cc4-4d36-90b5-bf1baddb26ca" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_CityAreaCode_1cb945d9-1cc4-4d36-90b5-bf1baddb26ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ac4d2e26-3843-4542-ac2c-210f7656c684" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_LocalPhoneNumber_ac4d2e26-3843-4542-ac2c-210f7656c684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_c1fe44f0-c391-475d-9f40-8100e4f0889c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_WrittenCommunications_c1fe44f0-c391-475d-9f40-8100e4f0889c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_150b047c-2951-4d1e-8f72-aa770559003c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_SolicitingMaterial_150b047c-2951-4d1e-8f72-aa770559003c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_04c0fa07-0500-43bd-9d12-f05946c78dc1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_PreCommencementTenderOffer_04c0fa07-0500-43bd-9d12-f05946c78dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_197501e0-d138-434e-b315-cc32047a2de6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_197501e0-d138-434e-b315-cc32047a2de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_21f91b75-cb04-45bc-920c-33da5053db64" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_Security12bTitle_21f91b75-cb04-45bc-920c-33da5053db64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_e2639c12-d795-4062-9f56-dd42dec4b4ce" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_TradingSymbol_e2639c12-d795-4062-9f56-dd42dec4b4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f1172c11-cca9-4ff4-98c6-690ddea57413" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_SecurityExchangeName_f1172c11-cca9-4ff4-98c6-690ddea57413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_efc71e43-f129-4a44-9502-644d954cf0fc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityEmergingGrowthCompany_efc71e43-f129-4a44-9502-644d954cf0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_20f1c46e-6bce-47ac-b1e0-aa686ef84d9f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_aecaaa78-cd4a-4025-b81c-9d0a0b00bd12" xlink:to="loc_dei_EntityCentralIndexKey_20f1c46e-6bce-47ac-b1e0-aa686ef84d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>letterheadlogoa521.jpg
<TEXT>
begin 644 letterheadlogoa521.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" $%!G(# 2(  A$! Q$!_\0
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MM=?N[(@I/,H_WCBLL.W&&/'O3HYG5@0QIIB.FL?B#?P_>F9QCN :UK+XFR@
M2@$>NVN'CNI/[Q%2"\D!SO:J4A-'HUIXXM[LX=8&^ORU<74K.= 3&03T*/FO
M,$U"1.2P)^E2Q:K-&05?!'3 YJU(AQ9Z4]S;D_*[J3V(R?TI/ML:@9<'/M7
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M!JQ"1@\9!JI#*AQAE;\:L"4D8Z$521-RSY@(P3TI>"  :KHPR#D9-2)PPP0
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MDQJV/0TP:+.I!,;5VR6Z3#*.C ]]P-2KX=\Z 2%R67H1VI\I/,<$=/D0Y,;
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M 3P< ]>*4D9R.".U-& N1QGTHST!P:9FQ>,G.0*7@\ DFFDGD]":<.F3QZ4
M"DD@9.,_G4H.2,@9J)>2.2<U(H.<$9/>@3!@"<#C%,<$ !1FI. >>U1D_,"W
M0=*T0QH W9!P*7! /.1]*;RK\CD]J=G;R,XZT$2$8[C@$CZ\8I=H!R0,4T>N
M<YH+$8!P#0(1^" ,8-'<<<4N/F!P>:  ,X(Q^5   23V[T;1DDX)HP>1UI.G
M!S@4 *<^6/2FCH,YYI<'!)H0=<]#02]F&!C.,TO?C Q0<@  $#I2,<8 P!VH
M) \DY&0:85 'MWIQ8DG!!H)X/44 -Z9R ,]J9*^T<8%*S%??-1,<MR<'M[4
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M<58@GN4!"S3)CL&(%=.WA6;>2$C8GWJ";PS<*#^[)(]"#GVH29+9C1ZW?0G
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M-F0<\TQV R 1S2D D@ <4A! ZYQ0 W<.@)/Z4S)+$\ "I H))(P#2$'IZ=:
M(^2..IHV9P3@D&GXYX.::>#P,@?K0 P@;1@#TXII7D$X!'%2,"V <X'Z4TJ
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M'D<8%?F2=S]@$.?6I(9I$/#L />HPASZ4_!QU !I/31 T3QZC(@R2KX]J?\
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MZ$"H"1@@4-$&.2.E3^0.,9%(R$X[DTTA$)0E@"/\*7R=P )(QVJ4)@G(_2G
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M[\,7^G@F6UG11U(4D?F*9+D8\5W<0D 32 Y[G_&K":S>*20R.!QRN2:D-KG
M="..XQ2"V0D$J"1Z4";'Q^))% WP*P/H<4XZU9W&X3VV,^JAA41MDS@ ]?6H
MI+,[NY]NF:: L-9Z->Y+)$C$=<%34<G@73KO @N'4GN'#5";$G/RG'YTPV#*
M>"5)[CK5)$R'S_#5@O[JY!';<G^%4;GP%?08PL<@]CS6A&\Z'"32H!TP35N#
M5KVW4YE60#^\!S3).7N/#M[;'+V\H'3@9JN;5XSAE92?48-=O!XGEC(+P(P'
M]WC-68-?L[A,3V[ $]P&% F<!]F/H.*>L'.3@8]*[Q[+0KP\K%&2<#JE0R^!
M+*YC!@F92?1@PII$MG&K<2P?<ED4GL"0*LQ:Y<QD,75R!T89K;NOAY-$0(Y4
M<'^\NW_&J5QX*O[=FVP^8!W4Y_\ KU5A%:/7RQ EA5AGJ"15A-7MYF.X2(2>
M!C( _"J<^D7%KQ)#+'GU4@5$8]O4$ 4Q,UHI(9B=LR'=VZ5*;<E<@ @\5B",
MLN0",TY1)!RKLI^M-,EHUQ;'(&"0*4V_T!]JSX=4N8V)$FX#U&:MQ:Z21YD"
MG/7:<528A_V;"@CD]Z22U#@ JK ^HS5B+4[21<$R1D],\@58@2*X4;)$8$]"
MW-,&8\FBP2M_JE!]N*@D\+0OG:SK^M=!)8F-B2I.:3[,-N< $4$-G,R^%Y1]
MQT<_E5271KB$C,3 >HYKKS;_ "]N33?+ R<$ 4T(XU[8K]X$$>M-\H DX((K
ML'MDF.&56'N,U7GT&VEX\O:3Z'%4E8#EEC //(IWE#C/>MV3PN"#LE*_49JM
M/X;N$&0%<CT-,39D^4"Q(QCO4?E<X .!5Y].F@/S1NN/4<5&T8STP102RL8=
MJ]^:B,9!!(X/I5X1@+D9I/*)((SF@12V@@YZ4",$9&15LVXQT_.F-;G.<CCI
MZ57D)WZ%9D(X SFFB/*9Z"K(B*]>2.U->W*G&"1UII"96*9<Y!(-&W'0G%3>
M41UP*0H5P"#S3)&!=PYP/QYH\KY<X()XSZ5,(,].*>L/R@D$4[Z 5#$2V">E
M.$8R<$ 'O5C[.HP6 S1Y8 Z<BFD)H@CMRP(Z"GK:D'&[(J>-0%&3R*1N/4X-
M4B4QGV<LPZ'-'V4<D+D^U*KD-@#CJ>,4HDW X)'M0$MQA55P0,D^U1R1%\E0
M0?T-3,"!SD 4A!( ]*!%=D8GGG-+L)4$=14I&<8P#FG*AYQ\P--"14*'=DCF
MDV8^M7%0;3E01^6*:R*^00,^W:K&5&)W'/:E\O S@ =:MI#&<\$$4UXP_ 89
M/MC-!$MRLRX88S@48 ZC)%6)(&4C+$@\=*9Y#'H,@?YS0(@(XQC %*$)88R#
M4RP$=5))IRJ0H!'/?B@")8C@DD#/M08L@X&2:E)5< G&:$53D#F@"-$'/ )J
M4QJ  1UJ0H  !CZXI&RWH *"&12-M[8QTJ)F//.!4KIC&5!]/>F;0 <@@_2@
M1%MW$X()H9#MP#G/I4K8 XS@"F*F[)R?K0 SROF)X!_.E\OG)&#4F .#SD4
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M &<@=.M#0CIV[5*7XP >::Q)((H CVCUXI&'&1R33Q&7;&,BGK;@MCI_2@"
M1$G  Q2B(Y .2:LI!L;CG_/6I$MV8D(C$MZ#- %(6AY)YQ3UMU7&0 16G#H=
MU*HQ"X'OQ_.K$?A.:3!=XT&/7- &+Y><D9R:5(B>G05OIX6C3 >5R1Z "IX]
M&MX>0A;'J<T <U]GY SFGIILL@PD3MGVKI1!'&0515'L*:Q.2!F@#!70YVQE
M53ZFI%T!NKR ?05K,IQQU-,=0!R0!0!GC184Y)9B/>G+8Q1CB-"?SJQ)<Q1]
M70CVYJ"34H$X#,V*  08484*#[8IIAV\$C\*@GUM%)PI('O5237FY*J!G\:
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MG]ONOM5VMLD<>\(.6ZDLPX%?2 _X-M_VH_\ H7O#'_@\BK[ _P"")G[*E_\
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M!(H; /##@C!!KZ<_97_X),?$;]H#2[?5$L;?P[H<X#1WVJ%HQ,OK&@!9A[X
M/K7UQ\)_V---_:$_X*/?%+QGK]O#?>&/#>K((86 >*_NC$A"GU5 ,D=R5'J*
M^^8HEMXU2-%2-!M55& H] /2M\QX@G&,84OB:3;[-J]C# Y+"3E.I\-VEYV9
M^=>E_P#! >P-D@O?'\@N/XO(TL;/PR^:Y3X@_P#!OCJ<EM(WA[QYI=Q-_!'?
MV3PAOJR%\?E7Z%^+/VD/ ?@;5'L=6\5Z+97D1P\+W +H?0@9P?K71>#O&^D?
M$'0TU/1-1M=4L)&*+/;N'0D'!&1W%>0LYQ\/?<G;T5OR/4>58*7NJ/XO_,_G
MO_;"_8#^(7[(>I0+XNT41:?>,4MM1MG\ZSN& R5#CHV/X6 /M7SEK6F[%88
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M5*]2GZ/]#=DBCEQN0?RK6^'_ ,(/$'Q<\3P:)X4T75M?U>Y/[JSL+5[B5_\
M@*@G'/6NG_8V_9L\3?MI_'[0_ 'AFW!OM5DW3W3#,5A;KS)._P#LJO;N< <D
M5_1M^RU^Q_\ "S_@FW\#9X=(BT_2;73K7[3K?B&_*K<7>U<O++*?NKQD(#M'
M8=S[&;9U3P24$N:;V7^9Y65Y1/%MR;Y8+=_Y'XB^#?\ @@5^TYXOTR.[/@NR
MTE) &$>H:I!#+]"H8D'V.*P?B[_P1,_:4^#ND37]Y\.[S6;. %GDT6XCOW4
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MRV6E-%&V#U'G%"1WZ5X"XAS#$.^$H:>C?XZ(]MY%@:&F*K:^J7^;/S1\7?\
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MR(QU,;]/P/\ C6BD)H]5%P 00<XJ9)@PR#G/(XK@]-^,&D7>T//) Q[.A/\
M+-=#IGBRQU(+Y-W!(1_=<9IW$=&)AM/;C@"IE?)ZXQ63%=AV# CGOG(JS%<
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MFDK7^6_X'[AKP !T%?DS_P %W/VD9[[]H[PWX&TZZVVWAC3OM=VJL1_I$['
M..XC53_P.OUBO;R.PM99YF"10H9'8\!0!DG\J_G$_:M^,L_Q^_:H\<^,&D::
M#6-7F>V/7;;JVR(?@BK7G\,8;GQ#JO[*_%Z?E<[>(<1R4%37VG^"_I'[.?\
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MMHKF^MT?"W.HRJ6W,.XCB9 ,]"S^M?M3\"/!,/PW^"GA'P_;Q+##HNCVMDJ
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M .9_1!^PO^SE8?LG_LI^#?!5G%'%+IFGI)?N!@SW<@WS.3WRY(^@'I7X-_\
M!6?]K_4?VN/VR_%%\;N23PYX;NI-&T2WWYCB@B;:T@'3,CAG)]"!V%?T<:K:
MS7.EW,5LZ0SR1,D3L,JC$$ GV!K\;[S_ (-B?'U]>S3R?%'PHTDSL[$Z?<$D
MDY)ZU\=PYCL-3Q%3$XR5I/:]^NY]7G^"Q%2A3P^%C>*WVZ6L?F"LIP#GI7UO
M_P $7/VJM0_9K_;A\,VQNWC\/^-IUT358"V(Y/,R(9".F4E*D'T+#O7T*O\
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M0!&8@.<BAE&,8YI^,GT I6&!S@F@",(%_&FE.Y)XJ7:" 3P*1D![@&@#]_\
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M/F3#=<:/*Q^6.4@ ,C9PK]R,'!P6X'_@F?\ L2?\-Q?M!C1;ZXFL_"^A6_\
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M#X+_ /!+']GN'QK\1-*M?B%XSN9$M[2"\(^S2W14DQPQM\H10"Q=U9L+D8)
MKYZB_P""V%A_;@34_@Y\*+S09&*R6EMI96X\H]A*Q*[@._EX/H*[;_@Y0\7L
M_BWX5:")&"VMI?Z@R#(&9'A0,>Q_U1 ],GUK\O6FRW?%+A[+88_!QQN8-SG.
M[U;5E=I))-);7T'Q!F<\!C7@L E"$++1)W=DVVVFWO;4_7_XF_\ !//X:_MV
M_LVV7Q7^!%HGAW5M1MFN%T4,([2YE0D26S+DB&96!4%3L.!Q@[A\+?L__M#_
M  R^"%WXDTKXJ_""_P#&>JQW*PPQR:I-ITFF-&766-E0C)+;>O(VU^@__!N5
MXCFU+]D'Q;IDCRNFF^*Y9(]S$A%DM;?Y1Z#<C''JQ/<U\E_\%_OV?++X3_M@
MV?B?3;9+:T\?Z:+V=$7:ANXF\J5A[LOEL?4L3U-<>48Z?]H5LCQ,Y2BF^1\S
M4E:SMS)I[>?1K9G9FV"A_9]'.\-",9-+F5DXN^E^5IK?\^Z/O+]BG]CK]GG]
MI7X"^%?B9I_PCT_2EUY)I8[&]U"YOEA\N>2'#!Y"CY,9/*]Z\4_:6_9?^$7[
M*/QK\9?%SXVR6]SH6IZF(O!_@G25427\<<*+O= 5^0$?=RJ*,;B2P6OIG_@C
M9G_AVI\+O^O:]_\ 3A<U^57_  6\^(6J^*_^"A7BVRU&]FN+30([:QL(2V$M
MHO)60JHZ#+NQ)[DUY&2QQ6)SBOA/;24(\R^)M\JE:R;;M?2[WL>OG4L+ALGH
M8OV,7.7*U[J2YG&]VDE>VMEM<^X/V+?^"R7PL^*7Q1TGX??\*T@^']CKMPME
MI<T7D26IE(VI'*JHFTN<*"-W) /'([+_ (*L_P#!-#PG\8?@3XA\9^$='MM
M\<>&+.74E;381"FKQ1(7DADC489RH)1@-VX $X-?CK^R9?D?M5_#)5!.?%FE
MCU_Y?(J_I&^,(!^$GBD$ @Z1=_\ HEZGB+#+)LPHUL W'FW5V[V?6^]^I7#N
M)EG.7UJ..2ERZ)V2M==+=NA_,3)JKXRTLASU^8U7GU@ 8+LQSZUCR7!/<G%1
MM)P,G-?K9^1FK+JP X;(JM)J9R1N//%4'EZCFF,_) /% %U[[<,$Y Z<U&U^
M%&3SGI5)Y@,@'K4<DISUSG\A0!=.H[6R#_A31J.23SGZU1,HX YIAEY.3P*
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M/V0=5^&OAGP3XETJ]UB]M9Y+O49H?+ACAE$AP$))8E0.P&2:^$/^"?/QS?\
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M$=PWCJZT3=MP=MFH&/IF4U^BZ\@\@YKQK]BGX4+\(?!_C>U6 0#5_'>NZL%
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MMG9LS11)#A1RW))Y)SZU\4Q;BH&"<5[I_P $QY%A_P""@OP?=R$7_A*+/DG
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M<3"[235[]-_T+XDQ>)H4Z=7#RLG=/;Y?J?77_$3O\0<X/PT\(@?]?EQ4B_\
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MN7R1"9E]T(-8>J?#V09(@GA;W0[:UC63)Y&<%+:D=AC]::UD7P.M=+<^#KJ
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MO?/\6_#I4T^4R/F6[LNEO-[X \LGGE 3UK[IK^87]@7]LW6?V$/VB]+\=:5
M^H6L2-::GI_G&-=0M7QNC)P0&!"LIP<%17Z2?\10OAWM\*-:)_["T7_Q%?*9
MKD%?ZPYX:-XO7IH^J/H\NSFBJ*C7E9K3KJ?&?_!R5HIO_P#@IMJSB1%)T#31
M@@Y_U1KZ_P#^#;C_ (*$66J_#0? 7Q9J4<.M:(\EQX8DF? O;5CN>V&?XXV+
M,!G)5CC[M?G1_P %,_VIH?\ @H%^U#J'Q#L]%D\.)<V-M8QV<L_GL!"FW<S
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M'XOZZ_C+59H65-,T[?:6%FQ7&XR!A)*P.2/N+[&N)_X(83-^Q9_P4(^,_P
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MDE8%?^-B269@ ,X R!D_-W_!RG^U3IEQ8^#OA'I]REQ?VUS_ ,)#JRQMN^S
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MXP"14R2$=1C-,AFA%?N,?,0:N6/B*[LP?+N)4 .<*QK'C?))R>*EC<MQT!H
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MBO1O^"C/_!*72?VRKMO%'AW4(/#GCN*$1O+,K&SU15&$$VT%E8  !U!XX*G
MQ^88?.:>6\08F.+TC4:U[=5\K,_3\1D]3,LAPTL)K*">G?H_G='Y82ZQ\.-*
M.Y;*]5AQA)@Q_E6;??$GP5&Y6&PUJ10./]("@>W2M3XX?\$[/C/\ KNX&N^
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M*U]-\13V(17"-'Z.W(KFS=S.,%R >N#BF@EARX%4F0T>AV'BBQOL+YACE/\
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M!_$:_G6U+4I=0U">ZN)-\]S(TLC]V9CDG\2:_H:_X)6MN_X)Y_"@XQG1%_\
M1CUQ^(&%I4\/"O"-IRE9M=?=?^1U\ 8JI4Q$Z$W>$8W2?35'Y2_\%XE5?^"B
M&N$@ ?V58?\ HFOG']F7]GGQ!^U?\;M%\#>&(E?4M8EPTK_ZJSA49DFD_P!E
M%!/J> .2*^B/^"];'_AXGKH&,#2=/_\ 1-?4O_!MO\!+6S^'/CGXF7$(;4-1
MOQX>LY&7F.&)(YI2OLSR1@D=XL=J]A9I_9_#U/$KXE"*7JU9?Y_(\?\ LO\
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MIUXU_9?_ &Q-9\(Z+X5^&FK:;:6-G.D^LZ$UU=LTD(8AI!*N0"< 8X%?7?\
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MK]8?^"H?B^Z\#_\ !/7XNZC8R-%=)X<N8$< ''F@1']'-?S)#(R#UJN$Z/\
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M_1<-8'_<L1__ "32'_@T3\.'_FN&L_\ A,1__)--9S@/^?J^Z7_R(?V9C?\
MGT_OC_\ )'X>[B. N ?>G*S'J ?QK]OS_P &B'AMB"?C?K/'_4L1_P#R32C_
M (-$_#:G(^-^L?\ A,1__)-']LX#_GZONE_\B+^S,;_SZ?WQ_P#DC\0TCSU.
M*D9B5(R :_;H_P#!HQX=/_-<-8'_ '+$?_R30?\ @T8\.D$'XX:QS_U+$?\
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MXU+'N;(()IXB(X(X'O7[)#_@U(T@?\UOU3_PEH__ )*I1_P:EZ2.GQPU0?\
M<K1__)5-9_EW_/U?=+_Y$3R;'_\ /I_?'_Y(_&HY&..:"<X/(-?LK_Q"E:23
MD_&_4C_W*L?_ ,E4G_$*3I/_ $7#4_\ PEH__DJG_;^7?\_?PE_\B"R3'_\
M/I_?'_Y(_&Q>F>:5<9SP:_9/_B%*TG_HN&IX]/\ A%8\?^E5 _X-2])'_-;M
M1S_V*L?_ ,E4?V_EW_/W\)?_ "(/)<?_ ,^G]\?_ )(_&])3'RA*GVJW!JA
M <9]Q7[#?\0INDC'_%[]2X_ZE6/_ .2J!_P:FZ4/^:WZEQ_U*L?_ ,E4UQ!E
MW_/W\)?_ "(O[$Q__/I_?'_Y(_(-5BNP#\K']139-,89*,& [=Z_8%/^#532
MT8%?CAJ0(_ZE5/\ Y*JPG_!K-8)C_B^&H$CU\*1__)55_K#EO_/W_P EE_\
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MDRS_ )^_^2R_^1#_ %?S'_GU^,?_ )(_(1;IQP9"/UIZZDZ\;V(/J*_78_\
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M_DLO_D0?#F9?\^OQC_\ )'Y3Q64W!6X5O^!UH6.I:K9+MBN&93VW!J_4@?\
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MI_\ )=.'_!MG(/\ FN%QQ_U**?\ R737%V4_\_?_ "67^0/A/-?^?7_DT?\
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M_P FC_F?$C>/'TN4F2P-N0V"T6^$G]:V-)^.)MBH<73J."'</@?4@5]M0?\
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MOP5IL,\T6H72R:C,N=MG9HP,TK'L F0/5BH')%=W_P %</'7A#Q9^VWXDL/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJQK1XGK.A'#8RG&M&.W->Z^:9^H'AKQA^Q5_P2VO9?$7@?5K[X[_ !0M%/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA@1D''%9TL90JSE3I34G'=)IM>II5P5>E"-2K!Q4MFTTGZ'GS X(QS2!&8X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA5JN-H.3:LG)\[BNC6B5W;JSJS+"8;!0J5Z5)2O-12=VHKD4NZW;LK]$>_\
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MSCO4T^.(Y!8RM/;O)Z&!1T7G\T&("\9P*U+ZR2YR0 KC\C67)$T;,K @BNO
MY91PG-[&_O6W?:]ONO9>21QX[,ZV+456MI?;SM?[[7?FV-:4GH2:CD<YXQ3C
MQ[8I-@;FN\\\C)/?)S29((.<']:F9 /0FHR1N[8S0!(;^2% I.Y1V/(I?,AE
MSO0H3W7G]*AE8$GN341)8G R: +?V6(\B88/M1538WI^E% ']A5%%%?R^?U
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD&@">X<KR,D5$'X/!P*4RCN1@TR0A1E2,&@!?,QW%,:3/ SFF>8.Y%)O'N:
M'[SZT4S>/>B@#^Q:BBBOY?/Z@"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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4K/FO_/\ E]X?ZLY5_P ^(_<?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>bsx-20210428_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://www.bostonscientific.com/20210428"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bsx-20210428.xsd" xlink:type="simple"/>
    <context id="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2021-04-28</startDate>
            <endDate>2021-04-28</endDate>
        </period>
    </context>
    <context id="i785bcfc838e745908dd8abcc7c606d22_D20210428-20210428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-28</startDate>
            <endDate>2021-04-28</endDate>
        </period>
    </context>
    <context id="i3b50dfb0808e483da456bd627ea01c95_D20210428-20210428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-28</startDate>
            <endDate>2021-04-28</endDate>
        </period>
    </context>
    <context id="i1ce7ace6aade485684be3abae18673d6_D20210428-20210428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-28</startDate>
            <endDate>2021-04-28</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl80L2ZyYWc6YjU0NDRmMzI3N2RlNDc2NjkwMDlhMmRiMTQ5M2VmYjcvdGFibGU6NWFhYzA5YzFjOTkxNGI3YWJkNWQ5YjM1MjE3NjI4MzYvdGFibGVyYW5nZTo1YWFjMDljMWM5OTE0YjdhYmQ1ZDliMzUyMTc2MjgzNl8yLTEtMS0xLTA_3d49edb4-5bff-48d2-b99c-08fc2105ab0c">0000885725</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl80L2ZyYWc6YjU0NDRmMzI3N2RlNDc2NjkwMDlhMmRiMTQ5M2VmYjcvdGFibGU6NWFhYzA5YzFjOTkxNGI3YWJkNWQ5YjM1MjE3NjI4MzYvdGFibGVyYW5nZTo1YWFjMDljMWM5OTE0YjdhYmQ1ZDliMzUyMTc2MjgzNl81LTEtMS0xLTA_4afb7f9c-21e3-487c-8639-f8aa6b08e948">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU3_6cb931fe-de16-4123-ba72-97daaf551f31">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8zNjc_c3a7fb33-7ced-4549-a556-eb8d8d696002">2021-04-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU4_9b4f7dd6-f5bd-4909-af07-1d16db58b82a">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MjAwNzIyYjI4YTZmNGVkOTg1NzM3YTI1NWU4Yjk4YzEvdGFibGVyYW5nZToyMDA3MjJiMjhhNmY0ZWQ5ODU3MzdhMjU1ZThiOThjMV8wLTAtMS0xLTA_90a42787-93f4-4fdf-bdc7-1e7517fe6891">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MjAwNzIyYjI4YTZmNGVkOTg1NzM3YTI1NWU4Yjk4YzEvdGFibGVyYW5nZToyMDA3MjJiMjhhNmY0ZWQ5ODU3MzdhMjU1ZThiOThjMV8wLTItMS0xLTA_2bc4e865-44ce-42c0-bd6a-ba9acbbbf1ba">1-11083</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MjAwNzIyYjI4YTZmNGVkOTg1NzM3YTI1NWU4Yjk4YzEvdGFibGVyYW5nZToyMDA3MjJiMjhhNmY0ZWQ5ODU3MzdhMjU1ZThiOThjMV8wLTQtMS0xLTA_7be986cc-f0e6-4d2d-9dbd-b9ac9b9cf8c6">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU5_48d7dc24-e065-4336-b36a-f3a479daf2fe">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDYw_ebb639a6-c4a2-4cf7-b25b-514747404e9f">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU0_1f28900e-7fec-4e0f-b374-8562cbbfb59f">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU1_e2d64ccc-2cef-48b6-8f0c-4a083cbb2ee8">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDUy_450c1b2f-8d03-46b5-839e-258e51c883fc">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDU2_c5dc1ece-dc20-4a1f-9a5f-ef9b5e739249">683-4000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6YzcxMzU0ZWE4ZTYxNDgxOWFmOWU5YTRiMDQ2ZjE4MDkvdGFibGVyYW5nZTpjNzEzNTRlYThlNjE0ODE5YWY5ZTlhNGIwNDZmMTgwOV8wLTAtMS0xLTA_061cde8b-cc4f-4c7d-9d3a-05de31399e56">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6YzcxMzU0ZWE4ZTYxNDgxOWFmOWU5YTRiMDQ2ZjE4MDkvdGFibGVyYW5nZTpjNzEzNTRlYThlNjE0ODE5YWY5ZTlhNGIwNDZmMTgwOV8yLTAtMS0xLTA_5a1380bd-fd4a-49a0-a0da-3d9b837c2e2c">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6YzcxMzU0ZWE4ZTYxNDgxOWFmOWU5YTRiMDQ2ZjE4MDkvdGFibGVyYW5nZTpjNzEzNTRlYThlNjE0ODE5YWY5ZTlhNGIwNDZmMTgwOV80LTAtMS0xLTA_a30c481f-691a-4f1e-aaee-ea0a0162e613">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6YzcxMzU0ZWE4ZTYxNDgxOWFmOWU5YTRiMDQ2ZjE4MDkvdGFibGVyYW5nZTpjNzEzNTRlYThlNjE0ODE5YWY5ZTlhNGIwNDZmMTgwOV82LTAtMS0xLTA_f65316ce-6e3e-4338-a8a7-7f9760f3adb5">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i785bcfc838e745908dd8abcc7c606d22_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18xLTAtMS0xLTA_b1869a2a-60c9-4ed0-b6eb-89f20254d842">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i785bcfc838e745908dd8abcc7c606d22_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18xLTItMS0xLTA_551530b6-7b9b-42cf-b1de-f963cf64262a">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i785bcfc838e745908dd8abcc7c606d22_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18xLTQtMS0xLTA_5c6fa9c7-b6a1-4204-9ce1-8d553288eebe">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i3b50dfb0808e483da456bd627ea01c95_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18yLTAtMS0xLTA_4ac06afb-0edb-483e-9430-cf5c60c2dd29">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3b50dfb0808e483da456bd627ea01c95_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18yLTItMS0xLTA_e2e86a5c-e9d8-4220-9b35-5ccc583f45a0">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3b50dfb0808e483da456bd627ea01c95_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18yLTQtMS0xLTA_4f864e70-a1d2-4b60-bd3a-0e44ec328bdb">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i1ce7ace6aade485684be3abae18673d6_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18zLTAtMS0xLTA_fa2e29cc-5734-4b66-a1c0-87aefee44efb">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i1ce7ace6aade485684be3abae18673d6_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18zLTItMS0xLTA_74cdb4d6-5402-41e1-9b93-6c774fe06b7f">BSX PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i1ce7ace6aade485684be3abae18673d6_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGFibGU6MTg2NTBlZThiY2ZkNDgxZmExZDUxNDVmOWQ5OTJmMGMvdGFibGVyYW5nZToxODY1MGVlOGJjZmQ0ODFmYTFkNTE0NWY5ZDk5MmYwY18zLTQtMS0xLTA_f3f80083-ecfc-4e08-acba-dfb5a2ad91ce">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428"
      id="id3VybDovL2RvY3MudjEvZG9jOmFiNzI0YTk4ZTNkNjQwYjhiNmIzZWQzN2FlYTA2YmZmL3NlYzphYjcyNGE5OGUzZDY0MGI4YjZiM2VkMzdhZWEwNmJmZl8xL2ZyYWc6OTFhY2I4MjkzNmM1NDE1MjlhNWZlZDY1Yzg1Y2M2YzUvdGV4dHJlZ2lvbjo5MWFjYjgyOTM2YzU0MTUyOWE1ZmVkNjVjODVjYzZjNV8xNDUz_4a28c295-c510-4609-8bce-992975f8314d">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140688093926360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Document<br></strong></div></th>
<th class="th"><div>Apr. 28, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 28,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX PR A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M3=/!/:Z\%DL$H!9QE-PD'=S9KJ_&$J&2:G1R<W1P<VS6FM9[\CB<N= "0V\
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ 4C2<4I>*NQS     $P(   L
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M#Y-'+:1U;J7<>W@E6XY9QW]:_@!02P,$%     @ 4C2<4B0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( %(TG%)ED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    " !2-)Q2"[KAN.\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !2-)Q2
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( %(TG%)]H8\8'04  &$6   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !2-)Q2
MGZ ;\+$"  #B#   #0              @ %A#0  >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( %(TG%*7BKL<P    !,"   +              "  3T0  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( %(TG%(WU&O^-@$  "L"   /
M      "  281  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !2-)Q2)!Z;
MHJT   #X 0  &@              @ &)$@  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " !2-)Q299!YDAD!  #/ P  $P
M    @ %N$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  "X
%%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bsx-20210428.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CoverDocument</Role>
      <ShortName>Cover Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bsx-20210428.htm">bsx-20210428.htm</File>
    <File>bsx-20210428.xsd</File>
    <File>bsx-20210428_cal.xml</File>
    <File>bsx-20210428_def.xml</File>
    <File>bsx-20210428_lab.xml</File>
    <File>bsx-20210428_pre.xml</File>
    <File>q12021earningsrelease.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bsx-20210428.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 4,
   "dts": {
    "calculationLink": {
     "local": [
      "bsx-20210428_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bsx-20210428_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "bsx-20210428.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20210428_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20210428_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20210428.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 2,
   "memberStandard": 1,
   "nsprefix": "bsx",
   "nsuri": "http://www.bostonscientific.com/20210428",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210428.htm",
      "contextRef": "iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Document",
     "role": "http://www.bostonscientific.com/role/CoverDocument",
     "shortName": "Cover Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210428.htm",
      "contextRef": "iaee245a4a1ad44f188532cd8b96fe7ce_D20210428-20210428",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "bsx_A550MCPSSeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.50% MCPS, Series A",
        "label": "5.50% MCPS, Series A [Member]",
        "terseLabel": "5.50% MCPS, Series A"
       }
      }
     },
     "localname": "A550MCPSSeriesAMember",
     "nsuri": "http://www.bostonscientific.com/20210428",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SeniorNotedue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Note due 2027 [Member]",
        "label": "Senior Note due 2027 [Member]",
        "terseLabel": "Senior Note due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorNotedue2027Member",
     "nsuri": "http://www.bostonscientific.com/20210428",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000885725-21-000012-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885725-21-000012-xbrl.zip
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M^O@N._0Q<0=7E^ RO3>3%2>5S#=L6(+AIS0ZWWUQ1:*KG)X+P_)T6)V>5H[
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MQQ#A,,0!-:YIG((]XC#GPQJYG;L?$SK^PQIY O?.U_;MB,(5FU*LFZHFN-<
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M25"<=6$'>A\MQN&M#N,JM"M\ %U_^0JRF#6ADA=1(&Z]B[QT?\*;9]YWA)T
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MOO&-=KR_(X9M=1\70\?[R1CVU_)K0GG,O%X372RIBR4^>V4LWIH!/IBKA[
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M&RMNE?M Z$-J=YW9\:KW@: J]?O0.'<)VRGS>:Y8^:A6QEB:$2&(,56 (,(
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MKLK%JJS)/(L@1*3$)X81H62W(!.4:(;]$Q[7VHSQANR3QH>QL2M[K^OKNV%
MSJHB]WF;E[/WV"S5N2TR)C%BH9!G(]'[P(#HJ)!QJQ25./?19 PZ'EL>AL:N
M;+&NJ>R&N3BMH8,:L&_NGT]WK^C7'R/ZD5'A:;14$6RF*1%)MT1'#4BDTHC4
M*QT\&X&/[WLPC)-=V68=2>GMXN6X::Z@OA\+,TI2!I0$EFB,10!Q"9/$^X3C
M/6%Y@'1\:A[Y,8R=7=EW'57U3<]$X*]P-KUEW)WG;0$9QW4Y<PJ=Q:*);9;K
MOF-&/:[&@I54)L&E8S2O#^T.(V17=EK74G7#1)S7MOM6X]GMW%5%A@UW8CQ6
MOZ",1 52CDV53$D( BGVP@D_QB.]%:/#6-B5W=3GZ[DEI>'MC;^PY0SZ%UXB
M8XI[QK"664-$C/TKNBE)#0T!K%3BVPISA/)PW_:P=\UV9<]T;76W8J_T[1SJ
M&=+]W[JZ;B]P5KRTY6T&T2L&N$J/C&,85F 8DG*2"A&,%#[2.,9:Y@<N#&-E
MMW9+U]=Z*Y Y0OUJ6QQCNW3S%]QFG$;F10HD=1YPV6X]<5WO9&VJ4X@:PQCO
M:<P#X\,PV94-U/7U'0V0E]-'BF)\7UZ_6)SH?G1?QG_]XO]02P,$%     @
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M:1JEQFQ[+!'V<'\\N7V0W'8.YVAPT@6A/"TJ4@A3._W(;=*TQ4NUVL+Y"6G
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MTG8&ZGLU$].>S<0(\N%]M7$F*RLAT,53U#0#MH#N:,[J.:!7NQ5XE.V[=0[
MAK'C]/G>1_Z*Z5:DQ0GND*'*-<3'G\%6UD"P<(3P<8RWM"4/+M6/KA;AVH;
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MFGU0I>;<1OWHSS[ZLP%VN9$DPOYO* +>G^P=T[+)Y >=M$=>Z :"C.B$N%Y
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MO8*?C6JI6&Z4BI52@7QX7ZF>_:IT!MACP+\-H!I,)*TBRSV;J&R[+O;P?#K
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M3#-E0)U\ZGGV!'X,@Y'S^?\#4$L! A0#%     @ 4C2<4C.J-/]1%@  .YL
M !               ( !     &)S>"TR,#(Q,#0R."YH=&U02P$"% ,4
M" !2-)Q25?2VA6$#  "P#   $               @ %_%@  8G-X+3(P,C$P
M-#(X+GAS9%!+ 0(4 Q0    ( %(TG%+1M)=5B@$  .T"   4
M  "  0X:  !B<W@M,C R,3 T,CA?8V%L+GAM;%!+ 0(4 Q0    ( %(TG%(R
M7@<<Q @  +<^   4              "  <H;  !B<W@M,C R,3 T,CA?9&5F
M+GAM;%!+ 0(4 Q0    ( %(TG%+_:7IN7PT  /=[   4              "
M < D  !B<W@M,C R,3 T,CA?;&%B+GAM;%!+ 0(4 Q0    ( %(TG%(--XQ[
M5@@  %I!   4              "  5$R  !B<W@M,C R,3 T,CA?<')E+GAM
M;%!+ 0(4 Q0    ( %(TG%*=<B(.L4(  )QC!  9              "  =DZ
M  !Q,3(P,C%E87)N:6YG<W)E;&5A<V4N:'1M4$L%!@     '  < RP$  ,%]
$      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
